Verition Fund Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-248,837
Closed -$6.62M 3229
2025
Q4
$6.2M Sell
248,837
-117,055
-32% -$2.95M 0.02% 728
2025
Q3
$9.32M Buy
365,892
+46,516
+15% +$1.15M 0.04% 568
2025
Q2
$7.74M Sell
319,376
-32,992
-9% -$769K 0.03% 695
2025
Q1
$8.93M Buy
352,368
+248,509
+239% +$6.5M 0.04% 511
2024
Q4
$2.76M Sell
103,859
-70,086
-40% -$1.9M 0.01% 1340
2024
Q3
$5.03M Buy
173,945
+49,011
+39% +$1.43M 0.03% 851
2024
Q2
$3.5M Sell
124,934
-631
-0.5% -$17.4K 0.02% 934
2024
Q1
$3.48M Sell
125,565
-21,762
-15% -$604K 0.02% 903
2023
Q4
$4.24M Buy
147,327
+13,819
+10% +$418K 0.03% 502
2023
Q3
$4.43M Buy
133,508
+36,039
+37% +$1.27M 0.05% 489
2023
Q2
$3.58M Buy
97,469
+9,215
+10% +$359K 0.05% 455
2023
Q1
$3.6M Buy
88,254
+14,689
+20% +$634K 0.05% 479
2022
Q4
$3.77M Sell
73,565
-79,966
-52% -$3.83M 0.06% 411
2022
Q3
$6.72M Buy
153,531
+103,397
+206% +$5.02M 0.08% 310
2022
Q2
$2.63M Sell
50,134
-1,038
-2% -$52.9K 0.05% 521
2022
Q1
$2.65M Buy
51,172
+46,672
+1,037% +$2.42M 0.03% 761
2021
Q4
$266K Sell
4,500
-17,331
-79% -$859K ﹤0.01% 2060
2021
Q3
$939K Buy
21,831
+4,691
+27% +$208K 0.01% 956
2021
Q2
$671K Buy
+17,140
New +$667K 0.01% 964
2021
Q1
Sell
-23,482
Closed -$864K 1720
2020
Q4
$864K Buy
23,482
+10,566
+82% +$388K 0.01% 538
2020
Q3
$450K Sell
12,916
-64,477
-83% -$2.26M 0.01% 614
2020
Q2
$2.4M Buy
+77,393
New +$2.63M 0.08% 196
2020
Q1
Sell
-57,250
Closed -$2.13M 945
2019
Q4
$2.13M Buy
57,250
+36,315
+173% +$1.29M 0.04% 260
2019
Q3
$714K Sell
20,935
-10,179
-33% -$370K 0.02% 507
2019
Q2
$1.28M Buy
+31,114
New +$1.24M 0.04% 355
2018
Q3
Sell
-28,353
Closed -$976K 1406
2018
Q2
$976K Sell
28,353
-2,002
-7% -$68.4K 0.06% 417
2018
Q1
$1.02M Buy
+30,355
New +$1.04M 0.08% 353
2017
Q1
Sell
-30,117
Closed -$928K 1402
2016
Q4
$928K Buy
30,117
+19,856
+194% +$606K 0.08% 292
2016
Q3
$330K Buy
+10,261
New +$343K 0.04% 729
2016
Q2
Sell
-9,645
Closed -$271K 1009
2016
Q1
$271K Buy
9,645
+1,075
+13% +$30.7K 0.04% 517
2015
Q4
$262K Sell
8,570
-4,078
-32% -$128K 0.05% 333
2015
Q3
$377K Sell
12,648
-131
-1% -$4.2K 0.1% 273
2015
Q2
$407K Buy
+12,779
New +$416K 0.07% 238
2014
Q4
Sell
-24,656
Closed -$692K 587
2014
Q3
$692K Buy
24,656
+5,817
+31% +$163K 0.1% 166
2014
Q2
$531K Buy
+18,839
New +$537K 0.06% 247
2014
Q1
Sell
-47,442
Closed -$1.38M 617
2013
Q4
$1.38M Buy
47,442
+30,280
+176% +$881K 0.25% 72
2013
Q3
$467K Buy
+17,162
New +$467K 0.07% 225

Other funds holding PFE

Verition Fund Management's PFE Position: Q1 2026 in Review

Verition Fund Management sold out of Pfizer (PFE) in Q1 2026, closing a stake of 248,837 shares — an estimated $6.62M sold.

Verition Fund Management first reported a position in PFE in Q3 2013 and held it in 37 quarters. The position peaked at $9.32M in Q3 2025. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Verition Fund Management reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
  • Verition Fund Management sold 248,837 Pfizer shares in Q1 2026, an estimated $6.62M.
  • Verition Fund Management first reported a position in Pfizer in Q3 2013 and held it in 37 quarters.
  • Verition Fund Management's Pfizer position peaked at $9.32M in Q3 2025.
  • 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.